Supplementary Figure 2 from A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer
Authors:
- Andrew X. ZhuAZAndrew X. Zhu
- Richard S. FinnRFRichard S. Finn
- Mary MulcahyMMMary Mulcahy
- Jayne GurtlerJGJayne Gurtler
- Weijing SunWSWeijing Sun
- Jonathan D. SchwartzJSJonathan D. Schwartz
- Rita P. DalalRDRita P. Dalal
- Adarsh JoshiAJAdarsh Joshi
- Rebecca R. HozakRHRebecca R. Hozak
- Yihuan XuYXYihuan Xu
- Marek AncukiewiczMAMarek Ancukiewicz
- Rakesh K. JainRJRakesh K. Jain
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)